Back to company

ENDOGEN ApS: Financial statements 2019

CVR: 29813337

ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -47,897 and a net result of DKK -48,651 compared with DKK -25,908 the year before. Equity amounted to DKK 97,270. The solvency ratio was 88.6%. The company had 1 employee in the financial year.

Gross Profit
-47,897 kr.
Profit/Loss
-48,651 kr.
Equity
97,270 kr.
Total Assets
109,770 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--48 t.-49 t.97 t.1
2018--26 t.-26 t.83 t.1
20170-7 t.-7 t.36 t.-
20160-13 t.-14 t.43 t.-
201519 t.-16 t.-16 t.56 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

ENDOGEN ApS: The 2018 annual report is outMar 25, 2019

ENDOGEN ApS has published its annual report for 2018. Gross profit came to DKK -25,583, and the net result was DKK -25,908.

Simon Glerup Pedersen joins ENDOGEN ApS as directorJan 10, 2019

As of January 10, 2019, Simon Glerup Pedersen is registered as director of ENDOGEN ApS.

About ENDOGEN ApS

ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.